⌘K (Command K) to search

Sign in Sign up free

Insider · CIK 0001350778

Aisling Capital II LP

Reports to the SEC for 5 companies · NEW YORK, NY

Transactions

10

Companies

5

Filings

4

CIK

0001350778

Forms 4 and 5

Insider transactions

10 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2015-04-24	ESPREsperion Therapeutics, Inc.S Sale	10% Owner	SSale	−5,743 sh	$108.00	−$620K	1,898,851
2015-04-24	ESPREsperion Therapeutics, Inc.S Sale	10% Owner	SSale	−61.7K sh	$106.10	−$6.55M	1,837,125
2015-04-23	ESPREsperion Therapeutics, Inc.S Sale	10% Owner	SSale	−150K sh	$109.10	−$16.4M	1,904,594
2013-10-22	ADMAADMA BIOLOGICS, INC.P Purchase	10% Owner	PPurchase	+412K sh	$8.50	+$3.5M	3,620,143
2013-07-01	ESPREsperion Therapeutics, Inc. · Warrant to Purchase Common StockJ Other	10% Owner	JOther	+71.2K sh	—	—	71,237
2013-07-01	ESPREsperion Therapeutics, Inc. · Series A Preferred StockC Conversion	10% Owner	CConversion	−1.82M sh	—	—	0
2013-07-01	ESPREsperion Therapeutics, Inc.C Conversion	10% Owner	CConversion	+1.82M sh	—	—	1,816,475
2013-07-01	ESPREsperion Therapeutics, Inc.P Purchase	10% Owner	PPurchase	+238K sh	$14.00	+$3.33M	2,054,594
2013-07-01	ESPREsperion Therapeutics, Inc. · Warrant to Purchase Preferred StockJ Other	10% Owner	JOther	−498K sh	—	—	0
2012-02-07	MELINTA THERAPEUTICS, INC. /NEW/P Purchase	10% Owner	PPurchase	+1.21M sh	$6.00	+$7.28M	3,293,060

Recent filings

4

Accepted (ET)
Apr 274
Esperion Therapeutics, Inc.0000950142-15-000894
SEC(opens sec.gov)
Oct 234
ADMA BIOLOGICS, INC.0000950142-13-002123
SEC(opens sec.gov)
Jul 14
Esperion Therapeutics, Inc.0001179110-13-011142
SEC(opens sec.gov)
Feb 94
ELMS STEVE0000950142-12-000248
SEC(opens sec.gov)

Companies

5

Address

888 SEVENTH AVENUE 30TH FLOOR

NEW YORK, NY, 10106